已收盤 02-06 16:00:00 美东时间
+0.020
+0.60%
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
2025-11-14 10:43
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从12美元升至15美元;Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至107美元
2025-11-13 09:58
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
2025-11-12 11:43
Canaccord Genuity analyst Joseph Vafi maintains Repay Holdings (NASDAQ:RPAY) with a Buy and maintains $12 price target.
2025-11-11 21:11
An update from Repay Holdings ( ($RPAY) ) is now available. On October 27, 2025...
2025-10-29 05:54
Innovative AP Automation Platform and Payment Technology Integration Enhances Accounting Processes and E-invoicing WorkflowsATLANTA--(BUSINESS WIRE)-- Repay Holdings Corporation (NASDAQ: RPAY) ("REPAY"), a leading
2025-10-07 20:40
Canaccord Genuity analyst Joseph Vafi maintains Repay Holdings (NASDAQ:RPAY) with a Buy and maintains $12 price target.
2025-08-25 21:10
Morgan Stanley analyst James Faucette maintains Repay Holdings (NASDAQ:RPAY) with a Equal-Weight and raises the price target from $4.5 to $5.
2025-08-12 20:32
Repay Holdings ( ($RPAY) ) has released its Q2 earnings. Here is a breakdown of...
2025-08-12 11:58
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to rep...
2025-08-11 16:32